Alzumab Uses, Dosage, Side Effects and more

Alzumab is under investigation in clinical trial NCT04605926 (A Study to Evaluate the Efficacy and Safety of Alzumab in Subjects Hospitalized With COVID-19).

Trade Name Alzumab
Generic Itolizumab
Itolizumab Other Names Itolizumab
Weight 25mg
Type Injection
Groups Investigational
Therapeutic Class
Manufacturer
Available Country India
Last Updated: January 7, 2025 at 1:49 am

How Alzumab works

Alzumab binds to CD6 which modulates T-lymphocyte activation and proliferation. It is an efficacious immunomodulatory compound investigated for treating psoriasis. Currently, the full mechanisms of action are still unclear.

Innovators Monograph

*** Taking medicines without doctor's advice can cause long-term problems.
Share